CAMBRIDGE, Mass.--(BUSINESS WIRE)--In presentations to investors today and over the next week, Biogen Idec (NASDAQ: BIIB) CEO James C. Mullen will outline key growth opportunities and review the company’s long-range strategic and financial goals. Mullen is scheduled to speak at the Thomas Weisel Partners Healthcare Conference at 8 a.m. today in Boston and the Bear Stearns Healthcare Conference on Sept. 10 in New York. Both presentations will be available via webcast on the Investor Relations section of www.biogenidec.com. Supplemental information in the form of a slide presentation will also be accessible on the internet at the same location at the time of each presentation and will remain on the Biogen Idec website until at least September 30, 2007.
